A Safety and Efficacy Study of a Synthetic Biolubricant in an Equine Model of Post-Traumatic Osteoarthritis.
Abstract: Post-traumatic osteoarthritis (PTOA) is a common cause of lameness in the horse. There is no cure, therefore treatments are aimed at reducing pain and improving the joint environment by modifying inflammatory pathways or by viscosupplementation. Here, we report the safety and efficacy of the biolubricant (poly(2-methacryloyloxyethyl phosphorylcholine; pMPC) to mitigate the physical, gross, histological, and biochemical effects of arthritis. We created an osteochondral fragment in the middle carpal joint of one limb in 16 horses to induce PTOA; the contralateral limb served as a sham-operated joint. Two weeks postoperative, half (n = 8) of the horses received a single injection of pMPC in the PTOA joint, while the other half received saline. All sham-operated joints (n = 16) received saline. We conducted clinical evaluations weekly while synovial fluid biomarkers were measured biweekly during the 70-day study period. Subsequently, we performed postmortem gross and histologic analyses. Horses in which PTOA joints were treated with pMPC exhibited mild increases in clinical data, including lameness, effusion, and flexion scores. Similarly, synovial cell count, total protein, and prostaglandin E2 values were higher for pMPC-treated joints. Radiographic changes included significantly higher osteophyte scores in pMPC-treated joints at the terminal timepoint. The biolubricant may demonstrate some chondroprotective effects with lower total erosion scores and higher cartilage glycosaminoglycan content. In summary, when pMPC is administered to PTOA joints, the biolubricant induces a mild inflammatory response but may offer some chondroprotective effects in horses.
Publication Date: 2025-02-01 PubMed ID: 39943174PubMed Central: PMC11815898DOI: 10.3390/ani15030404Google Scholar: Lookup
The Equine Research Bank provides access to a large database of publicly available scientific literature. Inclusion in the Research Bank does not imply endorsement of study methods or findings by Mad Barn.
- Journal Article
Summary
This research summary has been generated with artificial intelligence and may contain errors and omissions. Refer to the original study to confirm details provided. Submit correction.
This study investigates the safety and efficacy of a synthetic compound, biolubricant (pMPC), in managing the symptoms and effects of post-traumatic osteoarthritis (PTOA) in horses.
Objective and Methodology of the Research
- The research focuses on the problem of post-traumatic osteoarthritis (PTOA), a common cause of lameness in horses for which there is no cure. The treatments for this condition are typically aimed at lowering pain and improving the environment in the horse’s joints by modifying inflammatory reactions or by viscosupplementation.
- The researchers conducted a study on 16 horses, creating an osteochondral fragment in the middle carpal joint of one limb in each horse, to induce PTOA.
- The experiment made use of a synthetic biolubricant (pMPC) to examine its impact on the physical, gross, histological, and biochemical effects of arthritis. Two weeks post-operative, half of the horses were treated with a single injection of pMPC in the affected joint, while the other half served as a control group and received saline. The contralateral limbs without induced PTOA (sham-operated joints) in all horses also received saline.
Observations and Findings
- During the 70-day study period, clinical evaluations occurred weekly, while synovial fluid biomarkers were measured biweekly. Postmortem gross and histologic analyses were performed after this period.
- Joints treated with pMPC showed minor increases in clinical data, such as lameness, effusion (excess liquid in the joint that causes swelling), and flexion scores. In addition to these, synovial cell count, total protein, and prostaglandin E values were also higher in pMPC-treated joints.
- More significant osteophyte (bony growth in the joint) scores were recorded at the final stage of the study, suggesting potentially negative radiographic changes related to pMPC treatment.
- However, the biolubricant also seemed to show some chondroprotective effects, as seen in lower total erosion scores and more significant cartilage glycosaminoglycan content. This suggests that while pMPC may prompt a slight inflammatory reaction, it may also offer some measure of protection to the cartilage in the joints of horses suffering from PTOA.
Potential Implications
- This research indicates that pMPC could be an option for managing PTOA in horses. Despite causing a mild inflammation, the biolubricant might offer some level of chondroprotection.
- However, further research and trials may be required to fully understand the long-term effects and clinical implications of using this biolubricant treatment for horses suffering from PTOA.
Cite This Article
APA
Luedke LK, Seabaugh KA, Cooper BG, Snyder BD, Wimmer MA, McIlwraith CW, Barrett MF, Kawcak CE, Grinstaff MW, Goodrich LR.
(2025).
A Safety and Efficacy Study of a Synthetic Biolubricant in an Equine Model of Post-Traumatic Osteoarthritis.
Animals (Basel), 15(3).
https://doi.org/10.3390/ani15030404 Publication
Researcher Affiliations
- Gail Holmes Equine Orthopaedic Research Center, Translational Medicine Institute, Department of Clinical Sciences, College of Veterinary Medicine and Biomedical Sciences, Colorado State University, Fort Collins, CO 80523, USA.
- Gail Holmes Equine Orthopaedic Research Center, Translational Medicine Institute, Department of Clinical Sciences, College of Veterinary Medicine and Biomedical Sciences, Colorado State University, Fort Collins, CO 80523, USA.
- Departments of Chemistry and Biomedical Engineering, Boston University, Boston, MA 02215, USA.
- Department of Orthopedic Surgery, Boston Children's Hospital, Boston, MA 02115, USA.
- Department of Orthopedic Surgery, Rush University, Chicago, IL 60612, USA.
- Gail Holmes Equine Orthopaedic Research Center, Translational Medicine Institute, Department of Clinical Sciences, College of Veterinary Medicine and Biomedical Sciences, Colorado State University, Fort Collins, CO 80523, USA.
- Gail Holmes Equine Orthopaedic Research Center, Translational Medicine Institute, Department of Clinical Sciences, College of Veterinary Medicine and Biomedical Sciences, Colorado State University, Fort Collins, CO 80523, USA.
- Gail Holmes Equine Orthopaedic Research Center, Translational Medicine Institute, Department of Clinical Sciences, College of Veterinary Medicine and Biomedical Sciences, Colorado State University, Fort Collins, CO 80523, USA.
- Departments of Chemistry and Biomedical Engineering, Boston University, Boston, MA 02215, USA.
- Gail Holmes Equine Orthopaedic Research Center, Translational Medicine Institute, Department of Clinical Sciences, College of Veterinary Medicine and Biomedical Sciences, Colorado State University, Fort Collins, CO 80523, USA.
Grant Funding
- 000000 / Boston University, The Coulter Foundation
Conflict of Interest Statement
A patent was filed by the university on the polymers and is available for licensing. No IP has been licensed to the authors.
References
This article includes 39 references
- Allen K, Thoma L, Golightly Y. Epidemiology of Osteoarthritis. Osteoarthr. Cartil. 2022;30:184–195.
- Seabaugh K, Barrett M, Rao S, McIlwraith C, Frisbie D. Examining the Effects of the Oral Supplement Biota Orientalis in the Osteochondral Fragment-Exercise Model of Osteoarthritis in the Horse. Front. Vet. Sci. 2022;9:858391.
- McIlwraith C. Traumatic Arthritis and Posttraumatic Osteoarthritis in the Horse. 2016. pp. 33–48.
- Wang X, Hunger D, Jin X, Ding C. The Importance of Synovial Inflammation in Osteoarthritis: Current Evidence from Imaging Assessments and Clinical Trials. Osteoarth. Cartil. 2018;26:165–174.
- Frisbie D, Ghivizzani S, Robbins P, Evans C, McIlwraith C. Treatment of Experimental Equine Osteoarthritis by in Vivo Delivery of the Equine Interleukin-1 Receptor Antagonist Gene. Gene Ther. 2002;9:12–20.
- Frisbie D, Kawcak C, Trotter G, Powers B, Walton R, McIlwraith C. Effects of Triamcinolone Acetonide on an in Vivo Equine Osteochondral Fragment Exercise Model. Equine Vet. J. 1997;29:349–359.
- Hraha T.H, Doremus K.M, Mcilwraith C.W, Frisbie D.D. Autologous Conditioned Serum: The Comparative Cytokine Profiles of Two Commercial Methods (IRAP and IRAP II) Using Equine Blood. Equine Vet. J. 2011;43:516–521.
- Kawcak C.E, Frisbie D.D, McIlwraith W, Werpy N.M, Park R.D. Evaluation of Avocado and Soybean Unsaponifiable Extracts for Treatment of Horses with Experimentally Induced Osteoarthritis. Am. J. Vet. Res. 2007;68:598–604.
- Cooper B, DeMoya C, Sikes K, Frisbie D, Phillips N, Nelson B, McIlwraith C, Kawcak C, Goodrich L, Snyder B. A Polymer Network Architecture Provides Superior Cushioning and Lubrication of Soft Tissue Compared to a Linear Architecture. Biomater. Sci. 2023;11:7339–7345.
- DeMoya C, Joenathan A, Lawson T, Felson D, Schaer T, Bais M, Albro M, Makela J, Snyder B, Grinstaff M. Advances in Viscosupplementation and Tribosupplementation for Early-Stage Osteoarthritis Therapy. Nat. Rev. Rheumatol. 2024;20:432–451.
- McNary S, Athanasiou K, Reddi A. Engineering Lubrication in Articular Cartilage. Tissue Eng. Part B Rev. 2012;18:88–100.
- Dedinaite A. Biomimetic Lubrication. Soft Matter 2012;8:273–284.
- Lawson T, Makela J, Klein T, Snyder B, Grinstaff M. Nanotechnology and Osteoarthritis; Part 1: Clinical Landscape and Opportunities for Advanced Diagnostics. J. Orthop. Res. 2021;39:465–472.
- Samaroo K, Tan M, Putnam D, Bonassar L. Binding and Lubrication of Biomimetic Boundary Lubricants on Articular Cartilage. J. Orthop. Res. 2017;35:548–557.
- Cooper B, Bordeianu C, Nazarian A, Snyder B, Grinstaff M. Active Agents, Biomaterials, and Technologies to Improve Biolubrication and Strengthen Soft Tissues. Biomaterials 2018;181:210–226.
- Zappone B, Ruths M, Greene G, Jay G, Israelachvili J. Adsorption, Lubrication, and Wear of Lubricin on Model Surfaces: Polymer Brush-like Behavior of a Glycoprotein. Biophys. J. 2007;92:1693–1708.
- Coles J, Chang D, Zauscher S. Molecular Mechanisms of Aqueous Boundary Lubrication by Mucinous Glycoproteins. Curr. Opin. Colloid Interface Sci. 2010;15:406–416.
- Gonzales G, Hoque J, Kaeo C, Zauscher S, Varghese S. Grafting of Cationic Molecules to Hyaluronic Acid Improves Adsorption and Cartilage Lubrication. Biomater. Sci. 2024;12:4747–4758.
- Wathier M, Lakin B, Bansal P, Stoddart S, Snyder B, Grinstaff M. A Large-Molecular-Weight Polyanion, Synthesized via Ring-Opening Metathesis Polymerization, as a Lubricant for Human Articular Cartilage. J. Am. Chem. Soc. 2013;135:4930–4933.
- Xie R, Yao H, Mao A, Zhu Y, Qi D, Jia Y, Gao M, Chen Y, Wang L, Wang D. Biomimetic Cartilage-Lubricating Polymers Regenerate Cartilage in Rats with Early Osteoarthritis. Nat. Biomed. Eng. 2021;5:1189–1201.
- Lakin B, Cooper B, Zakaria L, Grasso D, Wathier M, Bendele A, Freedman J, Snyder B, Grinstaff M. A Synthetic Bottle-Brush Polyelectrolyte Reduces Friction and Wear of Intact and Previously Worn Cartilage. ACS Biomater. Sci. Eng. 2019;5:3060–3067.
- Wathier M, Lakin B, Cooper B, Bansal P, Bendele A, Entezari V, Suzuki H, Snyder B, Grinstaff M. A Synthetic Polymeric Biolubricant Imparts Chondroprotection in a Rat Meniscal Tear Model. Biomaterials 2018;182:13–20.
- Tnibar A. Intra-Articular 2.5% Polyacrylamide Hydrogel, a New Concept in the Medication of Equine Osteoarthritis: A Review. J. Equine Vet. Sci. 2022;119:104143.
- Tnibar A, Persson A-B, Nielsen H, Svalastoga E, Westrup U, McEvoy F, Knudsen J, Thomsen P.D, Berg L.C, Jacobsen S. Evaluation of a Polyacrylamide Hydrogel in the Treatment of Induced Osteoarthritis in a Goat Model: A Randomized Controlled Pilot Study. Osteoarthr. Cartil. 2014;22:S477.
- Vishwanath K, McClure S, Bonassar L. Polyacrylamide Hydrogel Lubricates Cartilage after Biochemical Degradation and Mechanical Injury. J. Orthop. Res. 2022;41:63–71.
- Narins R, Schmidt R. Polyacrylamide Hydrogel Differences: Getting Rid of the Confusion. J. Drugs Dermatol. 2011;10:1370–1375.
- Kester W. Guide for Veterinary Services and Judging of Equestrian Events. American Association of Equine Practitioners; Lexington, KY, USA: 1991. Definition and Classification of Lameness; p. 19.
- Frisbie D, Kawcak C, McIlwraith C, Werpy N. Evaluation of Polysulfated Glycosaminoglycan or Sodium Hyaluronan Administered Intra-Articularly for Treatment of Horses with Experimentally Induced Osteoarthritis. Am. J. Vet. Res. 2009;70:203–209.
- Frisbie D, McIlwraith C, Kawcak C, Werpy N. Evaluation of Intra-Articular Hyaluronan, Sodium Chondroitin Sulfate and N-Acetyl-d-Glucosamine Combination versus Saline (0.9% NaCl) for Osteoarthritis Using an Equine Model. Vet. J. 2013;197:824–829.
- McClure S, Peitzmeier M, Jackman B, Evans R, Ziegler C, Ganta C. Serial Injections of 4% Polyacrylamide Hydrogel Have No Detrimental Effects in Equine Joints Following Clinical, Histologic, and Synovial Biomarker Evaluation. Am. J. Vet. Res. 2024;85:ajvr.24.01.0016.
- Christensen L, Camitz L, Illigen K, Hansen M, Sarvaa R, Conaghan P. Synovial Incorporation of Polyacrylamide Hydrogel after Injection into Normal and Osteoarthritic Animal Joints. Osteoarth. Cart. 2016;24:1999–2002.
- Thampi P, Tabbaa S, Johnstone B, Wimmer M, Laurent M, McIlwraith C, Frisbie D. Surface Topography as a Tool to Detect Early Changes in a Posttraumatic Equine Model of Osteoarthritis. J. Orthop. Res. 2022;40:1349–1357.
- Frisbie D, Al-Sobayil F, Billinghurst R, Kawcak C, McIlwraith C. Changes in Synovial Fluid and Serum Biomarkers with Exercise and Early Osteoarthritis in Horses. Osteoarth. Cart. 2008;16:1196–1204.
- Jones D, Barber S, Doige C. Synovial Fluid and Clinical Changes After Arthroscopic Partial Synovectomy of the Equine Middle Carpal Joint. Vet. Surg. 1993;22:524–530.
- Chakrabarti S, Porok T, Roy A, Patel D, Dasarathi S, Pahan K. Upregulation of IL-1 Receptor Antagonist by Aspirin in Glial Cells via Peroxisome Proliferator-Activated Receptor-Alpha. J. Alzheimers Dis. Rep. 2021;5:647–661.
- Palmer G, Guerne P, Mezin F, Maret M, Guicheux J, Goldring M, Babay C. Production of Interleukin-1 Receptor Antagonist by Human Articular Chondrocytes. Arthritis Res. Ther. 2002;4:226–231.
- Ehrle A, Lischer C, Lasarzik J, Einspanier R, Bondzio A. Synovial Fluid and Serum Concentrations of Interleukin-1 Receptor Antagonist and Interleukin-1ß in Naturally Occurring Equine Osteoarthritis and Septic Arthritis. J. Equine Vet. Sci. 2015;35:815–822.
- Machado T, Massoco C, Silva L, Fulber J, Moreira J, Baccarin R. Effects of Blood-Derived Products and Sodium Hyaluronate on Equine Synovial Fluid Cells and on Synovial Fluid from Osteochondrotic Joints of Horses after Arthroscopy and Administration of Treatment. J. Am. Vet. Res. 2019;80:646–656.
- Frisbie D, Kawcak C, Werpy N, Park R, McIlwraith C. Clinical, Biochemical, and Histologic Effects of Intra-Articular Administration of Autologous Conditioned Serum in Horses with Experimentally Induced Osteoarthritis. Am. J. Vet. Res. 2007;68:290–296.
Use Nutrition Calculator
Check if your horse's diet meets their nutrition requirements with our easy-to-use tool Check your horse's diet with our easy-to-use tool
Talk to a Nutritionist
Discuss your horse's feeding plan with our experts over a free phone consultation Discuss your horse's diet over a phone consultation
Submit Diet Evaluation
Get a customized feeding plan for your horse formulated by our equine nutritionists Get a custom feeding plan formulated by our nutritionists